Información del artículo
Resumen
La miocardiopatia hipertrófica no es una enfermedad aislada, sino un grupo caracterizado por la mutación de diferentes genes codificadores de proteínas sarcoméricas. Su expresión fenotípica depende de diferentes factores genéticos y ambientales. En este artículo se describe un caso de miocardiopatia hipertrófica en un contexto familiar durante el embarazo, y se describe su tratamiento durante éste y en el parto.
Abstract
Hypertrophic cardiomyopathy is not a single disease, but a group of diseases caused by mutations in genes encoding different sarcomeric proteins. The phenotype expression depends on multiple genetic and environmental factors. In this paper, we describe a familial case of hypertrophic cardiomyopathy during pregnancy, and the options available for management during pregnancy and delivery.
El Texto completo está disponible en PDF
Bibliografía
[1.]
E. Braunwald, C.E. Seidman, U. Sigwart.
Contemporary evaluation and management of hypertrophic cardiomyopathy.
Circulation, 106 (2002), pp. 1312-1316
[2.]
Q. Ciampi, S. Betocchi, R. Lombardi, F. Manganelli, G. Storto, M.A. Losi, et al.
Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy.
J Am Coll Cardiol, 40 (2002), pp. 278-284
[3.]
P.S. Bernstein, U. Magriples.
Cardiomyopathy in pregnancy: a retrospective study.
Am J Perinatol, 18 (2001), pp. 163-168
[4.]
I. González, E. Armada, J. Díaz, P. Gallego, M. García, A. Gon-zález, et al.
Guías de práctica clínica de la Sociedad Española de Cardiología en la gestante con cardiopatía.
Rev Esp Cardiol, 53 (2000), pp. 1474-1495
[5.]
P.B. McFaul, J.C. Dornan, H. Lamki, D. Boyle.
Pregnancy complicated maternal heart disease: a review of 519 women.
Br J Obstet Gynaecol, 95 (1988), pp. 861-867
[6.]
Plasencia W, Barber M, Eguiluz I, González N. Insuficiencia cardíaca por miocardiopatía dilatada [en prensa]. Prog Obstet Ginecol
[8.]
K.W. Van Hoevan, R.N. Kitsis, SD. Katz, M. Khalilullah.
Peri-partum versus idiopathic dilated cardiomiopathy in young woman. A comparison of clinical, pathological and prognostic features.
Int J Cardiol, 40 (1993), pp. 57-67
[9.]
Barber MA, Eguiluz I, Plasencia W, Rodríguez A, Martín M, García JA. Hipertensión pulmonar primaria y gestación [en prensa]. Prog Obstet Ginecol
[10.]
P. Zielinsky.
Role of prenatal echocardiography in the study of hypertrophic cardiomyopathy in the fetus.
Echocardiography, 8 (1991), pp. 661-668
[11.]
B.J. Maron.
Hypertrophic Cardiomyopathy. A systematic review.
JAMA, 287 (2002), pp. 1308-1320
[12.]
V. Probst, J.M. Langlard, M. Desnos, M. Komajda, J.B. Bouhour.
Familial hypertrophic cardiomyopathy. French study of the duration and outcome of pregnancy.
Arch Mal Coeur Vaiss, 95 (2002), pp. 81-86
[13.]
M.J. Ackerman, S.L. VanDriest, S.R. Ommen, M.L. Will, R.A. Nishi-mura, A.J. Tajik, et al.
Prevalence and age-dependence of malignant mutations in the betamyosin heavy chain and troponin T genes in hypertrophic cardiomyopathy. A compreensive outpatient perspective.
J Am Coll Cardiol, 39 (2002), pp. 2042-2048
[14.]
W.J. tMcKenna, J. Mogensen, P.M. Elliott.
Role of genotyping in risk factor assessment for sudden death in hypertrophic cardiomyopathy.
J Am Coll Cardiol, 39 (2002), pp. 2049-2051
[15.]
B.J. Maron, P. Spirito.
Impact of patient selection bases on the perception of hypertrophic cardiomyopathy and its natural history.
Am J Cardiol, 72 (1993), pp. 970-972
[16.]
F. Gadler.
Pacing in obstructive hypertrophic cardiomyopathy.
Eur Heart J Suppl, 3 (2001), pp. L32-37
[17.]
H. Watkins.
Sudden death in hypertrophic cardiomyopathy.
N Engl J Med, 372 (2000), pp. 422-424
[18.]
M.J. Kofflard, D.J. Waldstein, J. Vos, F.J. Ten.
Prognosis in hypertrophic cardiomyopathy.
Am J Cardiol, 72 (1993), pp. 939-943
[19.]
R. Ferrari, L. Rydén.
Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management.
Eur Heart J Suppl, 3 (2001), pp. L1-2
[20.]
W.J. McKenna, L. Monserrat.
Identificación y tratamiento de los pacientes con miocardiopatía hipertrófica y riesgo de muerte súbita.
Rev Esp Cardiol, 53 (2000), pp. 123-130
[21.]
U. Sigwart.
Non-surgical myocardial reduction for patients with hypertrophic obstructive cardiomyopathy.
Eur Heart J Suppl, 3 (2001), pp. L38-42
[22.]
J.X. Quin, T. Shiota, H.M. Lever.
Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
J Am Coll Cardiol, 38 (2001), pp. 1994-2000
[23.]
B.J. Maron, W.K. Shen, M.S. Link.
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
N Engl J Med, 342 (2000), pp. 365-373
[24.]
B. Fagih, M. Sami.
Safety of antiarrhythmics during pregnancy: case report and review of the literature.
Can J Cardiol, 15 (1999), pp. 1137
[25.]
E. López, P.A. Doblas, I. Eguiluz, M.A. Barber, S. Monis, J. Seoa-ne, et al.
Antiarrítmicos en el embarazo.
Clin Invest Gin Obstet, 30 (2003), pp. 18-23
[26.]
Cate F.J. Ten.
Prognosis of hypertrophic cardiomyopathy.
JInsur Med, 28 (1996), pp. 42-45
[27.]
C. Autore, M.R. Conte, M. Piccininno, P. Bernabo, G. Bonfiglio, P. Bruzzi, et al.
Risk associated with pregnancy in hypertrophic cardiomyopathy.
J Am Coll Cardiol, 40 (2002), pp. 1864-1869
[28.]
R. Thaman, A. Varnava, M.S. Hamid, S. Firoozi, B. Sachdev, M. Condon, et al.
Pregnancy related complications in women with hypertrophic cardiomyopathy.
Heart, 89 (2003), pp. 752-756
[29.]
S. Wilansky, T. Belcik, R. Osborn, R. Carpenter.
Hypertrophic cardiomyopathy in pregnancy. The use of two-dimensional and Doppler echocardiography during labor and delivery: a case report.
J Heart Valve Dis, 7 (1998), pp. 355-357
[30.]
GD. Oakley, K. McGarry, D.G. Limb, C.M. Oakley.
Management of pregnancy in patients with hypertrophic cardiomyopathy.
BMJ, 1 (1979), pp. 1749-1750
[31.]
Plasencia W, Eguiluz I, Barber MA, García JA. Infarto agudo de miocardio y embarazo [en prensa]. Prog Obstet Ginecol
[32.]
C. Gohlke, J. Acar, C. Oakley, E. Butchard, D. Burckhart, E. Bodnar, et al.
Guidelines for prevention of thromboembolic events in valvular heart disease: study group of the Working Group on Valvular Heart Disease of the European Society of Cardiology.
Eur Heart J, 16 (1995), pp. 1320-1330
[33.]
M.J. Tessler, R. Hudson, M. Naugler, D.R. Biehl.
Pulmonary oedema in two parturients with hypertrophic obstructive cardiomyopathy.
Can J Anaesth, 37 (1990), pp. 469-473
[34.]
P. Spirito, C. Rapezzi, P. Bellone, S. Betocchi, C. Autore, M.R. Con-te, et al.
Infective endocarditis in hypertrophic cardiom-yopathy: prevalence, incidence, and indications for antibiotic prophylaxis.
Circulation, 99 (1999), pp. 2132-2137
[35.]
K. Oohara, T. Yamazaki, H. Kanou, A. Kobayashi.
Infective endocarditis complicated by mycotic cerebral aneurysm: two case reports of women in the peripartum period.
Eur JCardiothorac Surg, 14 (1998), pp. 533-535
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
